Lactic acid polymers as biodegradable carriers of fluoroquinolones: An in vitro study

被引:42
作者
Kanellakopoulou, K
Kolia, M
Anastassiadis, A
Korakis, T
Giamarellos-Bourboulis, EJ
Andreopoulos, A
Dounis, E
Giamarellou, H [1 ]
机构
[1] Sismanogl Gen Hosp, Athens Med Sch, Dept Internal Med 4, Athens 15126, Greece
[2] Athend Med Sch, Dept Propedeut Med 1, Athens, Greece
[3] Laiko Gen Hosp, Dept Orthopaed, Athens, Greece
[4] Athens Polytech Sch, Dept Chem Engn, Athens, Greece
关键词
D O I
10.1128/AAC.43.3.714
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
A biodegradable polymer of DL-dilactide that facilitates release of ciprofloxacin or pefloxacin at levels exceeding MICs for the causative microorganisms of chronic osteomyelitis is described. Duration and peak of release were found to depend on the molecular weight of the polymer. Its characteristics make it promising for treating chronic bone infections.
引用
收藏
页码:714 / 716
页数:3
相关论文
共 16 条
[1]   In vitro release of new quinolones from biodegradable systems: A comparative study [J].
Andreopoulos, AG ;
Korakis, T ;
Dounis, E ;
Anastasiadis, A ;
Tzivelekis, P ;
Kanellakopoulou, K .
JOURNAL OF BIOMATERIALS APPLICATIONS, 1996, 10 (04) :338-347
[2]  
CHAPINROBINSON AK, 1991, ANTIBIOTICS LAB MED, P295
[3]   IN-VITRO ELUTION OF CIPROFLOXACIN FROM POLYMETHYLMETHACRYLATE CEMENT BEADS [J].
DIMAIO, FR ;
OHALLORAN, JJ ;
QUALE, JM .
JOURNAL OF ORTHOPAEDIC RESEARCH, 1994, 12 (01) :79-82
[4]  
DOUNIS E, 1995, 14 ANN M EUR BON JOI, P35
[5]  
Eliopoulos G M, 1995, Drugs, V49 Suppl 2, P48
[6]   Chronic osteomyelitis caused by multi-resistant Gram-negative bacteria: evaluation of treatment with newer quinolones after prolonged follow-up [J].
Galanakis, N ;
Giamarellou, H ;
Moussas, T ;
Dounis, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 39 (02) :241-246
[7]   POLYLACTIDE/POLYGLYCOLIDE ANTIBIOTIC IMPLANTS IN THE TREATMENT OF OSTEOMYELITIS - A CANINE MODEL [J].
GARVIN, KL ;
MIYANO, JA ;
ROBINSON, D ;
GIGER, D ;
NOVAK, J ;
RADIO, S .
JOURNAL OF BONE AND JOINT SURGERY-AMERICAN VOLUME, 1994, 76A (10) :1500-1506
[8]  
Giamarellou H, 1995, Drugs, V49 Suppl 2, P58
[9]  
GORFREY K, 1992, MED USES STAT, P233
[10]  
Lew D P, 1995, Drugs, V49 Suppl 2, P100